Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug-related problem classification systems.

J W Foppe van Mil1, L O Tommy Westerlund, Kurt E Hersberger

  • 1van Mil Consultancy, Zuidlaren, The Netherlands. jwfvmil@planet.nl

The Annals of Pharmacotherapy
|April 1, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biomarker-Based Prediction of OATP1B1 Activity in Clinical Routine-Investigating Coproporphyrins as Markers for Drug-Drug-Gene Interactions.

Clinical pharmacology and therapeutics·2026
Same author

Genetic Determinants of Analgesic Responsiveness: A Focus on CYP2D6 and COMT Polymorphisms in Chronic Pain.

The Clinical journal of pain·2026
Same author

Association of Pharmacogenotyping and Patient-Reported Outcomes in Chronic Pain Management.

Health services insights·2025
Same author

Impact and Enablers of Pharmacogenetic-Informed Treatment Decisions-A Longitudinal Mixed-Methods Study Exploring the Patient Perspective.

Pharmacy (Basel, Switzerland)·2025
Same author

Pharmacogenotyping disproves genetic cause of drug-related problems in family history: a case report.

BMC anesthesiology·2024
Same author

Adherence Monitoring Package (AMoPac) in patients suspected of non-response to antihypertensive treatment: perceived usefulness by general practitioners.

BMJ open quality·2024

Classifying drug-related problems (DRPs) is challenging, with no single optimal system found. The Pharmaceutical Care Network Europe system Version 4 shows the most promise for pharmaceutical care and research.

Area of Science:

  • Pharmaceutical Care
  • Drug Therapy
  • Pharmacy Practice Research

Background:

  • Drug-related problems (DRPs) are critical to patient safety and effective medication use.
  • Standardized classification systems are needed for consistent identification and management of DRPs in pharmaceutical care.
  • Existing classifications vary in focus, terminology, and structure.

Purpose of the Study:

  • To critically review and appraise existing drug-related problem classifications.
  • To identify an optimal classification system for pharmaceutical care processes and research.
  • To evaluate classifications based on defined criteria for usability and validation.

Main Methods:

  • Conducted a literature search using MEDLINE and Yahoo for DRP classifications.

Related Experiment Videos

  • Reviewed English and German articles on pharmaceutical care and DRPs.
  • Assessed fourteen identified classifications against criteria including definition, validation, usability, and structure.

    • Main Results:

    • Fourteen DRP classifications with diverse focuses were identified.
    • Significant variation in terminology, definitions, and hierarchical structures was observed.
    • No single classification met all criteria for an optimal system; few were validated or tested for practice usability.

    Conclusions:

    • Computerized literature searches for DRP classifications proved difficult.
    • The Pharmaceutical Care Network Europe system Version 4 emerged as the closest to meeting the defined requirements for an optimal DRP classification.
    • Further validation and refinement of DRP classification systems are needed.